ArticleArchives of Razi Institute2023

Comparative Evaluation of Biosimilar Trastuzumab with Reference Trastuzumab Activity in HER2-Positive Breast Cancer Patients.

V AbdulHameed Saeed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.